A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 22314
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MI
Long Form : myocardial infarction
No. Year Title Co-occurring Abbreviation
2020 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. ADVANCE, CI, CTA, FFRCT, MACE, RR
2020 A novel mouse model of coronary stenosis mimicking Kawasaki disease induced by Lactobacillus casei cell wall extract. CA, KD, LCWE, PCNA, SMA, VSMCs
2020 A self-doping conductive polymer hydrogel that can restore electrical impulse propagation at myocardial infarct to prevent cardiac arrhythmia and preserve ventricular function. CMs, PAMB
2020 ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. ACS, ALCAM, CV, HR, PLATO
2020 alpha-Bisabolol protects against beta-adrenergic agonist-induced myocardial infarction in rats by attenuating inflammation, lysosomal dysfunction, NLRP3 inflammasome activation and modulating autophagic flux. ISO
2020 Altered adrenergic response in myocytes bordering a chronic myocardial infarction underlies in vivo triggered activity and repolarization instability. BVR, DADs, ISO
2020 Aminooxyacetic acid attenuates post-infarct cardiac dysfunction by balancing macrophage polarization through modulating macrophage metabolism in mice. AOAA
2020 An implantable system for long-term assessment of atrial fibrillation substrate in unanesthetized rats exposed to underlying pathological conditions. AF, ALDO
2020 An injectable chitosan/dextran/beta -glycerophosphate hydrogel as cell delivery carrier for therapy of myocardial infarction. beta-GP, CS, DEX, UC-MSCs
10  2020 An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction. COL
11  2020 Andrographolide Protects Against Adverse Cardiac Remodeling After Myocardial Infarction through Enhancing Nrf2 Signaling Pathway. Andr
12  2020 Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more. AF, MACE, OAC, RR
13  2020 Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data. MACE, VKA
14  2020 Application of the SCAI classification in a cohort of patients with cardiogenic shock. CI, CS, SCAI
15  2020 Association of lncRNA polymorphisms with triglyceride and total cholesterol levels among myocardial infarction patients in Chinese population. lncRNAs, MALAT1, SNPs
16  2020 Associations Between microRNA Polymorphisms and Development of Coronary Artery Disease: A Case-Control Study. CAD, miR
17  2020 Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition. CAD, CANTOS, CIRT, CRP, hs-CRP, IL-1ss, MACE, NLRP3
18  2020 Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction. CMR, LVEF, MACE
19  2020 Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark. COPD, STEMI
20  2020 Biodegradable polymer drug-eluting stent vs. contemporary durable polymer drug-eluting stents in patients with diabetes: a meta-analysis of randomized controlled trials. BP-DES, CI, DP-DES, RCTs, RR, TLR, TVR
21  2020 Bone marrow mesenchymal stem cells-derived exosomal microRNA-185 represses ventricular remolding of mice with myocardial infarction by inhibiting SOCS2. BMSCs, miRNAs, SOCS2
22  2020 Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation. HO-1, ISO, MDA, Nrf2, PLGA, PVA, Wog np
23  2020 Cardio-renal Exosomes in Myocardial Infarction Serum Regulate Proangiogenic Paracrine Signaling in Adipose Mesenchymal Stem Cells. AD-MSCs, MSCs
24  2020 Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. CAD, CV, CVD, HR, PCOS
25  2020 Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction. CAD, MMPs
26  2020 Changes in circulating endothelial microvesicles in men after myocardial infarction. EMV, HDL-C, LDL-C, TC
27  2020 Chitosan Hydrogel Enhances the Therapeutic Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells for Myocardial Infarction by Alleviating Vascular Endothelial Cell Pyroptosis. BMSCs, CS, MSCs
28  2020 CircRNA 010567 improves myocardial infarction rats through inhibiting TGF-beta1. circRNA, LVDd, LVDs, LVEF, LVFS, MF, RT-PCR, TGF-beta1, TUNEL
29  2020 Clinical and angiographic factors predicting fractional flow reserve and explaining the visual-functional mismatch in patients with intermediate coronary artery stenosis. BARI, FFR, LAD, MACE, MLD
30  2020 Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting. DAPT, DES, NACE, PCI
31  2020 Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update. COX
32  2020 Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trial. ESKD, HHF, MCO, PMPY
33  2020 Current advances in biodegradable synthetic polymer based cardiac patches. CAD
34  2020 Deferral Versus Performance of Revascularization for Coronary Stenosis With Grey Zone Fractional Flow Reserve Values: A Systematic Review and Meta-Analysis. FFR, HR, MACE, TVR
35  2020 Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types. CV, NSTEMI
36  2020 Definitions of post-coronary artery bypass grafting myocardial infarction: variations in incidence and prognostic significance. CABG, CI, HR, ULN
37  2020 Design and Rationale of the ERA-CVD Consortium PREMED-CAD-Precision Medicine in Coronary Artery Disease. CAD, CVDs, PREMED-CAD
38  2020 Development of Injectable Amniotic Membrane Matrix for Postmyocardial Infarction Tissue Repair. EF, HAM
39  2020 Dietary protein intake and kidney function decline after myocardial infarction: the Alpha Omega Cohort. SD
40  2020 Direct Anticoagulants and Risk of Myocardial Infarction, a Multiple Treatment Network Meta-Analysis. DOAC, RR
41  2020 Donor MSCs Release Apoptotic Bodies to Improve Myocardial Infarction via Autophagy Regulation in Recipient Cells. ABs, ECs, MSC, TFEB
42  2020 Dual antiplatelet therapy beyond 12 months versus for 12 months after drug-eluting stents for acute myocardial infarction. DAPT, DES, MACCE
43  2020 Effect of Operator Volume on In-Hospital Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Based on the 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry. K-PCI, K-PCI registry, PCI, STEMI
44  2020 Effect of Remote Ischemic Preconditioning on Patients Undergoing Elective Major Vascular Surgery: A Systematic Review and Meta-analysis. AKI, CI, RCTs, RIPC, RR
45  2020 Effectiveness of administering tranexamic acid to high-risk hip and knee arthroplasty patients: a systematic review protocol. DVT, PE, TIA
46  2020 Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis. ACEI, ARB, BB, CCB, CI, HF, HR, RR
47  2020 Effects of Myocardial Perfusion Defect on the Frontal QRS-T Angle in Anterior Versus Inferior Myocardial Infarction. ECG, MPD
48  2020 Effects of renin-angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. ACEI, ARB, CIs, DN, ESRD, MACEs, RCTs, RR
49  2020 Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono- and dual-antiplatelet therapy. APT, PA, PAD, PAR, PFCC, uTxB2, vWF
50  2020 Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention. IHD, RCTs, SD
51  2020 Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure. HF, SGLT2
52  2020 Exendin-4 Reduces Ventricular Arrhythmia Activity and Calcium Sparks-Mediated Sarcoplasmic Reticulum Ca Leak in Rats with Heart Failure. ECG, Ex-4, Ex9-39, RyR, SR
53  2020 Exercise protects the heart against myocardial infarction through upregulation of miR-1192. ---
54  2020 Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction. ADMSCs, BMMSCs, MSCs, MVD, NRCMs, UCB-MSCs
55  2020 Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair. BM-MSCs, Exo, MIF, MSC, NRCMs
56  2020 Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions. CAD, GS, TBA
57  2020 Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis. APD90, Egr-1, FGF21, rhbFGF21, VT
58  2020 Ginsenoside Re Preserves Cardiac Function and Ameliorates Left Ventricular Remodeling in a Rat Model of Myocardial Infarction. Gin-Re
59  2020 Haemin pre-treatment augments the cardiac protection of mesenchymal stem cells by inhibiting mitochondrial fission and improving survival. BM, HO-1, MSC
60  2020 High haemoglobin A1c level is a possible risk factor for ventricular fibrillation in sudden cardiac arrest among non-diabetic individuals in the general population. ECG, SCA
61  2020 History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial. CVD, ILI
62  2020 Hourly Exposure to Ultrafine Particle Metrics and the Onset of Myocardial Infarction in Augsburg, Germany. CI, PM, PNC, UFP
63  2020 ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction. ACS, ICD, LV, LVEF, VAs
64  2020 Immediate Carotid Endarterectomy Is Associated with Higher Risk in Symptomatic Patients. CEA
65  2020 Impact of Fast food Outlet Density on Incidence of Myocardial Infarction in the Hunter Region. FFD, LGA
66  2020 Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction - a prospective observational study. CYP2D6, EMs, GP, HR, IMs
67  2020 Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial. ACS, CAD, CI, DAPT, HR, IRF, PCI, PoCE
68  2020 In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative. CEA, TCAR
69  2020 In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes. ACS, CI, CKD, DES, DM, HR, ISR, PCI
70  2020 Incidence, predictors and validation of risk scores to predict postoperative mortality after noncardiac vascular surgery, a prospective cohort study. AKI, AUROC, CCI, CI, CKD, OR, PAD, POM, POSPOM, RBC, VS
71  2020 Infarct Zone: a Novel Platform for Exosome Trade in Cardiac Tissue Regeneration. CADs
72  2020 Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction. NET, PAD4
73  2020 Interleukin-38 alleviates cardiac remodelling after myocardial infarction. DCs, IL, TnI
74  2020 Intermedin attenuates cardiomyocytes hypoxia-injury through upregulating long noncoding RNA MALAT1. IMD, MALAT1, PI3K, RT-qPCR
75  2020 Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition. ASC, CCK-8, ELISA, LDH, NLRP3, OGD, PCR, TTC
76  2020 Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression. CHD, EF, FS, ISO group, KXS, KXS, LV, MMP, MMPs
77  2020 LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. ---
78  2020 LncRNA H19 ameliorates myocardial infarction-induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A. ceRNA, RIP
79  2020 LncRNA UCA1 protects cardiomyocytes against hypoxia/reoxygenation induced apoptosis through inhibiting miR-143/MDM2/p53 axis. ---
80  2020 Long-term metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trials. APs, MACE, RCTs
81  2020 Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test. CI, EST, HR, PCI, SIHD
82  2020 Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction. BP-DES, CI, DP-DES, HR, MACE, PS
83  2020 Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. CI
84  2020 Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery according to the synergy between percutaneous coronary intervention with taxus and cardiac surgery score. CABG, CI, MACE, PCI, TVR, ULMCA
85  2020 Long-Term Outcomes of Unprotected Left Main Coronary Artery Disease: Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention. CABG, MACCE, PCI, PSM, TVR, ULMCA
86  2020 Low-Volume High-Intensity Aerobic Interval Training Is an Efficient Method to Improve Cardiorespiratory Fitness After Myocardial Infarction: PILOT STUDY FROM THE INTERFARCT PROJECT. AC, CRF, HIIT
87  2020 Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages. PVA, SBP
88  2020 Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event. PA
89  2020 Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone. CIs, EPA, ORs, RCTs, TSA
90  2020 Metoprolol protects against myocardial infarction by inhibiting miR-1 expression in rats. Cx43, LAD
91  2020 microRNA-132 inhibits cardiomyocyte apoptosis and myocardial remodeling in myocardial infarction by targeting IL-1beta. IL-1beta, miRNAs
92  2020 MiR-574-5p promotes the differentiation of human cardiac fibroblasts via regulating ARID3A. HCFs
93  2020 MiR-590-3p regulates proliferation, migration and collagen synthesis of cardiac fibroblast by targeting ZEB1. HCFs
94  2020 miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders. AAV9, CIH
95  2020 Monocytes prime autoreactive T cells after myocardial infarction. alpha-MHC, CCR2, IMP, MLN
96  2020 Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review. ABI, CLI, CV, IC, MACE, PAD
97  2020 Multicenter experience with percutaneous coronary intervention for chronic total occlusion in Korean population: analysis of the Korean nationwide multicenter chronic total occlusion registry. CT, CTO, MACE, PCI
98  2020 Myocardial infarction in type 2 diabetes using sodium-glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning. DPP-4is, GLP-1RAs, SGLT2is
99  2020 Natural Heart Regeneration in a Neonatal Rat Myocardial Infarction Model. EF
100  2020 Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis Following Myocardial Infarction. ACS, BM, CVD, LAD, MACE, NLR, TLR